Quick Answer
Yubo International Biotech Ltd reported Total Assets of $847.1 thousand for the year ending 2025.
- Yubo International Biotech Ltd showed a decrease of -44.8% in Total Assets from 2024 to 2025.
- This data is from Yubo International Biotech Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2019 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: $14.0 thousand | Q2 2016: $3.0 thousand | Q4 2016: $3.0 thousand | Q1 2020: $1.0 thousand | Q2 2020: $0.00 | Q2 2020: $0.00 | Q1 2021: $3.91 million | Q2 2021: $4.18 million | Q3 2021: $4.36 million | Q1 2022: $4.47 million | Q2 2022: $4.05 million | Q3 2022: $3.72 million | Q1 2023: $2.11 million | Q2 2023: $1.96 million | Q3 2023: $1.90 million | Q1 2024: $1.55 million | Q2 2024: $1.73 million | Q3 2024: $1.65 million | Q1 2025: $1.17 million | Q2 2025: $1.05 million | Q3 2025: $953.2 thousand.
- Over the full 8 years of available data (2019 to 2025), Yubo International Biotech Ltd's Total Assets has grown by 21,077.4%.
- Historical annual values: Fiscal year 2025: $847.1 thousand | Fiscal year 2024: $1.53 million | Fiscal year 2023: $1.67 million | Fiscal year 2022: $2.35 million | Fiscal year 2021: $4.59 million | Fiscal year 2020: $2.44 million | Fiscal year 2020: $1.0 thousand | Fiscal year 2019: $4.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: